Venn Life Sciences (LON:VENN) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

Venn Life Sciences Holdings PLC (LON:VENN)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.

Venn Life Sciences Price Performance

The company has a current ratio of 2.30, a quick ratio of 1.48 and a debt-to-equity ratio of 35.83. The stock has a fifty day simple moving average of GBX 6.85 and a 200-day simple moving average of GBX 6.85. The stock has a market cap of £4.89 million and a price-to-earnings ratio of -2.14.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.